vimarsana.com

Latest Breaking News On - Carter bir - Page 1 : vimarsana.com

Reata Pharmaceuticals (NASDAQ:RETA) Receives New Coverage from Analysts at StockNews com

StockNews.com assumed coverage on shares of Reata Pharmaceuticals (NASDAQ:RETA – Free Report) in a research report released on Tuesday. The firm issued a sell rating on the stock. A number of other analysts have also recently weighed in on the stock. 888 restated a reiterates rating on shares of Reata Pharmaceuticals in a research note […]

Reata Pharmaceuticals (NASDAQ:RETA) Receives New Coverage from Analysts at StockNews com

StockNews.com started coverage on shares of Reata Pharmaceuticals (NASDAQ:RETA – Free Report) in a research note released on Friday morning. The firm issued a sell rating on the stock. RETA has been the topic of a number of other research reports. Jefferies Financial Group downgraded Reata Pharmaceuticals from a buy rating to a hold rating […]

StockNews com Begins Coverage on Reata Pharmaceuticals (NASDAQ:RETA)

StockNews.com initiated coverage on shares of Reata Pharmaceuticals (NASDAQ:RETA – Free Report) in a research report released on Friday morning. The brokerage issued a sell rating on the stock. Other research analysts also recently issued research reports about the stock. Stifel Nicolaus downgraded shares of Reata Pharmaceuticals from a buy rating to a hold rating […]

Reata Pharmaceuticals (NASDAQ:RETA) Sets New 12-Month High at $170 83

Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Get Free Report) reached a new 52-week high on Monday . The company traded as high as $170.83 and last traded at $170.83, with a volume of 25211 shares traded. The stock had previously closed at $170.32. Analysts Set New Price Targets A number of research firms have weighed in […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.